株式会社HIROTSUバイオサイエンス

Tokyo, JP · 1 known investors

HIROTSUS Bioscience develops N-NOSE, a cancer screening test that uses nematodes to detect trace odor markers in urine samples, enabling early cancer detection. The company operates in medical diagnostics and contributes to public health through research and development.

BiotechDigital HealthMedical Devices